DD
40
4
GPC
53
2
HON
58
3
EQT
59
5
CHRW
62
8
PH
63
4
GOOGL
45
2
APH
59
6
AMAT
36
6
F
55
3
NI
73
3
DHR
51
6
L
62
3
NRG
60
6
PLD
48
5
MUR
40
4
GRMN
48
2
KLAC
63
6
AEE
82
3
CINF
45
4
DD
40
4
GPC
53
2
HON
58
3
EQT
59
5
CHRW
62
8
PH
63
4
GOOGL
45
2
APH
59
6
AMAT
36
6
F
55
3
NI
73
3
DHR
51
6
L
62
3
NRG
60
6
PLD
48
5
MUR
40
4
GRMN
48
2
KLAC
63
6
AEE
82
3
CINF
45
4
Financhill
Back

ProShares Ultra Gold Vs. Novartis AG Industry Stock Comparison

Buy
76

UGL
ProShares Ultra Gold

Last Price:
$117.69
Seasonality Move:
1.47%
Buy
64

NVSEF
Novartis AG

Last Price:
$109.00
Seasonality Move:
5.79%
Buy
76
ProShares Ultra Gold (UGL) is a Buy

Is ProShares Ultra Gold a Buy, Sell or Hold?

  • The current ProShares Ultra Gold [UGL] share price is $117.69. The Score for UGL is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • UGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Novartis AG (NVSEF) is a Buy

Is Novartis AG a Buy, Sell or Hold?

  • The current Novartis AG [NVSEF] share price is $109.00. The Score for NVSEF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UGL Stock Price Chart

What is ProShares Ultra Gold's stock price today?

  • The ProShares Ultra Gold share price today is $117.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UGL is experiencing selling pressure, which indicates risk of future bearish movement.

NVSEF Stock Price Chart

What is Novartis AG's stock price today?

  • The Novartis AG share price today is $109.00
    The current trend is moderately bearish and NVSEF is experiencing slight buying pressure.

UGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.21 Buy
Relative Strength Index (14 RSI): 64.24 Buy
Chaikin Money Flow: -115943 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.43 - 115.29) Buy
Bollinger Bands (100): (94.38 - 109.6) Buy

NVSEF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.99 Buy
Relative Strength Index (14 RSI): 49.51 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

UGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 113.97 Buy
20-day SMA: 113.21 Buy
50-day SMA: 106.57 Buy
200-day SMA: 93.61 Buy
8-day EMA: 114.57 Buy
20-day EMA: 112.59 Buy
50-day EMA: 108.02 Buy
200-day EMA: 94.83 Buy

NVSEF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.98 Sell
20-day SMA: 109.72 Sell
50-day SMA: 104.18 Buy
200-day SMA: 106.37 Buy
8-day EMA: 110.9 Sell
20-day EMA: 109.54 Sell
50-day EMA: 106.41 Buy
200-day EMA: 104.31 Buy

ProShares Ultra Gold Earnings Growth & UGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novartis AG Earnings Growth & NVSEF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares Ultra Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novartis AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):